Literature DB >> 18190584

Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups.

Z Zhao1, F Kong, X Zeng, H F Gidding, J Morgan, G L Gilbert.   

Abstract

Serotype distribution and antibiotic resistance (AR) among group B streptococci (GBS) affect GBS disease prevention strategies, but vary among patient groups. A multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay was used to compare the distributions of GBS serotypes, serotype III subtypes and AR-associated genes among 666 invasive isolates from 663 patients, divided into five age groups: infants, early-onset (EO; 0-6 days) and late-onset (LO; 7-90 days); children (aged 3 months to 14 years); women of childbearing age (WCBA; aged 15-45 years); and other adults (males aged >15 years; females aged >45 years). Serotypes Ia and V and serosubtype III-1 accounted for 60% of infections. Serosubtype III-2, which corresponds to a virulent clone belonging to sequence type (ST)17, was relatively uncommon overall (7%), but was associated strongly with LO infant infections, in which it was significantly more common than in adult infections (25/104 (24%) vs. 9/392 (2%), p <0.0001) or in EO infections (25/104 (24%) vs. 14/155 (9%), p <0.005). Erythromycin resistance genes were found in 8% of all isolates (ermB 3%, ermA 2.5% and mefA/E 2%), in 11-15% of isolates of serotypes II and V and subtype III-1, but in none of the isolates of serosubtype III-2 (III-2, 0/49 vs. all others, 54/618 (9%), p <0.04). In summary, the virulent serosubtype III-2 was associated strongly with LO infant GBS infection, but was less likely than other serotypes or serosubtype III-1 to carry AR genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190584     DOI: 10.1111/j.1469-0691.2007.01914.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  24 in total

1.  Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program.

Authors:  M Granlund; P Axemo; K Bremme; A-L Bryngelsson; M Carlsson Wallin; C-M Ekström; S Håkansson; B Jacobsson; K Källén; E Spetz; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-13       Impact factor: 3.267

2.  Point prevalence study of antibiotic susceptibility of genital group B streptococcus isolated from near-term pregnant women in Calgary, Alberta.

Authors:  Deirdre Church; Julie Carson; Dan Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.

Authors:  L Lambertsen; K Ekelund; I C Skovsted; A Liboriussen; H-C Slotved
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-31       Impact factor: 3.267

4.  Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.

Authors:  S Kernéis; C Plainvert; J-P Barnier; A Tazi; N Dmytruk; B Gislain; J Loubinoux; F El Sayed; V Cattoir; N Desplaces; V Vernet; P Morand; C Poyart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-26       Impact factor: 3.267

5.  Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.

Authors:  E R Martins; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

6.  Molecular characterization of Streptococcus agalactiae isolated from pregnant women and newborns at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Mucheye Gizachew; Moges Tiruneh; Feleke Moges; Mulat Adefris; Zemene Tigabu; Belay Tessema
Journal:  BMC Infect Dis       Date:  2020-01-13       Impact factor: 3.090

7.  Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.

Authors:  Sarah Teatero; Allison McGeer; Donald E Low; Aimin Li; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

8.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

9.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

10.  Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.

Authors:  Areej Alhhazmi; Donna Hurteau; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.